研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2023 年 · Clinical Trials(临床试验)
112 篇,新的在前。点标题看作者和摘要。回到 2023 年
- Ivor Cribben and Anastasiou Andreas’s contribution to the Discussion of ‘the Discussion Meeting on Probabilistic and statistical aspects of machine learning’ · JRSSB · 2023-12-29 · 在第 1 页
- Using leave‐one‐out cross validation (LOO) in a multilevel regression and poststratification (MRP) workflow: A cautionary tale · SiM · 2023-12-26 · 在第 1 页
- Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity · SiM · 2023-12-20 · 在第 2 页
- Dealing with time‐dependent exposures and confounding when defining and estimating attributable fractions—Revisiting estimands and estimators · SiM · 2023-12-20 · 在第 2 页
- Evaluating a shrinkage estimator for the treatment effect in clinical trials · SiM · 2023-12-19 · 在第 2 页
- An extended Bayesian semi‐mechanistic dose‐finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information · SiM · 2023-12-18 · 在第 2 页
- Sample size calculation for multi-arm parallel design with restricted mean survival time · SMMR · 2023-12-13 · 在第 2 页
- New Estimands for Experiments with Strong Interference · JASA · 2023-12-11 · 在第 2 页
- Flexible evaluation of surrogate markers with Bayesian model averaging · SiM · 2023-12-11 · 在第 2 页
- A Bayesian adaptive biomarker stratified phase II randomized clinical trial design for radiotherapies with competing risk survival outcomes · SMMR · 2023-12-07 · 在第 2 页
- The staircase cluster randomised trial design: A pragmatic alternative to the stepped wedge · SMMR · 2023-11-30 · 在第 3 页
- Group sequential two‐stage preference designs · SiM · 2023-11-27 · 在第 3 页
- Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations · SiM · 2023-11-27 · 在第 3 页
- Sample size and predictive performance of machine learning methods with survival data: A simulation study · SiM · 2023-11-10 · 在第 4 页
- Cluster randomized trial designs for modeling time‐varying intervention effects · SiM · 2023-11-10 · 在第 4 页
- A Bayesian phase II proof‐of‐concept design for clinical trials with longitudinal endpoints · SiM · 2023-11-08 · 在第 4 页
- Improving transportability of randomized controlled trial inference using robust prediction methods · SMMR · 2023-11-07 · 在第 4 页
- Designing a phase‐III time‐to‐event clinical trial using a modified sample size formula and Poisson‐Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution · SiM · 2023-11-05 · 在第 4 页
- Sample sizes for estimating the sensitivity of a monitoring system that generates repeated binary outcomes with autocorrelation · SMMR · 2023-11-02 · 在第 5 页
- A frequentist design for basket trials using adaptive lasso · SiM · 2023-11-02 · 在第 5 页
- Minimization in randomized clinical trials · SiM · 2023-10-23 · 在第 5 页
- Graphical Model Inference with Erosely Measured Data · JASA · 2023-10-20 · 在第 5 页
- BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints · SiM · 2023-10-19 · 在第 5 页
- Authors' reply to the Discussion of ‘Estimating means of bounded random variables by betting’ · JRSSB · 2023-10-19 · 在第 5 页
- The survival‐incorporated median vs the median in the survivors or in the always‐survivors: What are we measuring? and Why? · SiM · 2023-10-12 · 在第 6 页
- Optimal study designs for cluster randomised trials: An overview of methods and results · SMMR · 2023-10-06 · 在第 6 页
- Network and covariate adjusted response‐adaptive design for binary response · SiM · 2023-09-26 · 在第 7 页
- Bayesian adaptive design for covariate‐adaptive historical control information borrowing · SiM · 2023-09-26 · 在第 7 页
- Inference on tree‐structured subgroups with subgroup size and subgroup effect relationship in clinical trials · SiM · 2023-09-21 · 在第 7 页
- Sample size optimization for clinical trials using graphical approaches for multiplicity adjustment · SiM · 2023-09-20 · 在第 7 页
- SAM: Self-Adapting Mixture Prior to Dynamically Borrow Information from Historical Data in Clinical Trials · Biometrics · 2023-09-18 · 在第 8 页
- Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes · SiM · 2023-09-14 · 在第 8 页
- Frequentist analysis of basket trials with one‐sample Mantel‐Haenszel procedures · SiM · 2023-09-05 · 在第 8 页
- Sample sizes required to estimate the protective efficacy of a vaccine when there is an unequal allocation of individuals across the vaccine and placebo groups · SMMR · 2023-08-30 · 在第 9 页
- Optimizing Treatment Allocation in Randomized Clinical Trials by Leveraging Baseline Covariates · Biometrics · 2023-08-28 · 在第 9 页
- Marta Catalano, Augusto Fasano, and Giovanni Rebaudo’s contribution to the discussion of ‘Martingale posterior distributions’ by Fong, Holmes and Walker · JRSSB · 2023-08-27 · 在第 9 页
- Study Design for Restricted Mean Time Analysis of Recurrent Events and Death · Biometrics · 2023-08-23 · 在第 9 页
- A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method · SiM · 2023-08-23 · 在第 9 页
- Selection of a statistical analysis method for the Glasgow Outcome Scale‐Extended endpoint for estimating the probability of favorable outcome in future severe TBI clinical trials · SiM · 2023-08-20 · 在第 10 页
- Bayesian design and analysis of two‐arm cluster randomized trials using assurance · SiM · 2023-08-20 · 在第 10 页
- Local continual reassessment methods for dose finding and optimization in drug-combination trials · SMMR · 2023-08-18 · 在第 10 页
- Does it decay? Obtaining decaying correlation parameter values from previously analysed cluster randomised trials · SMMR · 2023-08-17 · 在第 10 页
- Simple Bayesian models for missing binary outcomes in randomized controlled trials · SiM · 2023-08-13 · 在第 10 页
- Restricted mean survival time to estimate an intervention effect in a cluster randomized trial · SMMR · 2023-08-09 · 在第 10 页
- Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials · SMMR · 2023-07-28 · 在第 11 页
- Estimation of conditional power in the presence of auxiliary data · SiM · 2023-07-26 · 在第 11 页
- Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpoints · SMMR · 2023-07-25 · 在第 11 页
- A flexible micro-randomized trial design and sample size considerations · SMMR · 2023-07-25 · 在第 11 页
- A semi-Markov multistate cure model for estimating intervention effects in stepped wedge design trials · SMMR · 2023-07-14 · 在第 12 页
- Wilcoxon rank-sum tests to detect one-sided mixture alternatives in group sequential clinical trials · SMMR · 2023-07-11 · 在第 12 页
- Sample size determination for adaptive crossover trial in detecting gene-drug interactions · SMMR · 2023-07-11 · 在第 12 页
- Covariate adjustment in randomized clinical trials with missing covariate and outcome data · SiM · 2023-07-02 · 在第 13 页
- Economizing comparative Poisson clinical trials of multiple experimental treatments by testing against the same control · SMMR · 2023-06-29 · 在第 13 页
- Sample Size and Power Determination for Multiparameter Evaluation in Nonlinear Regression Models with Potential Stratification · Biometrics · 2023-06-25 · 在第 13 页
- Sample size for partially nested designs and other nested or crossed designs with a continuous outcome when adjusted for baseline · SiM · 2023-06-22 · 在第 13 页
- Single‐world intervention graphs for defining, identifying, and communicating estimands in clinical trials · SiM · 2023-06-21 · 在第 13 页
- Permutation‐based multiple testing corrections for P$$ P $$‐values and confidence intervals for cluster randomized trials · SiM · 2023-06-21 · 在第 13 页
- Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity · SiM · 2023-06-20 · 在第 14 页
- Dynamic Enrichment of Bayesian Small-Sample, Sequential, Multiple Assignment Randomized Trial Design Using Natural History Data: A Case Study from Duchenne Muscular Dystrophy · Biometrics · 2023-06-15 · 在第 14 页
- Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances · SiM · 2023-06-14 · 在第 14 页
- Defining and estimating effects in cluster randomized trials: A methods comparison · SiM · 2023-06-12 · 在第 14 页
- An overview of optimal designs under a given budget in cluster randomized trials with a binary outcome · SMMR · 2023-06-07 · 在第 15 页
- qTPI: A quasi-toxicity probability interval design for phase I trials with multiple-grade toxicities · SMMR · 2023-06-06 · 在第 15 页
- Matching ratio and sample size for optimal sequential testing with binomial data · SMMR · 2023-06-06 · 在第 15 页
- Statistical Thinking in Clinical Trials · JASA · 2023-05-30 · 在第 15 页
- Fully order restricted multi‐arm multi‐stage clinical trial design · SiM · 2023-05-15 · 在第 16 页
- Sample size estimation for comparing dynamic treatment regimens in a SMART: A Monte Carlo-based approach and case study with longitudinal overdispersed count outcomes · SMMR · 2023-05-11 · 在第 16 页
- Model-based adaptive randomization procedures for heteroscedasticity of treatment responses · SMMR · 2023-05-11 · 在第 16 页
- A Bayesian multi‐arm multi‐stage clinical trial design incorporating information about treatment ordering · SiM · 2023-05-09 · 在第 17 页
- Power and sample size calculations for rerandomization · Biometrika · 2023-05-03 · 在第 17 页
- Bayesian borrowing for basket trials with longitudinal outcomes · SiM · 2023-04-30 · 在第 17 页
- Confounding adjustment in the analysis of augmented randomized controlled trial with hybrid control arm · SiM · 2023-04-25 · 在第 17 页
- Sample size considerations for micro‐randomized trials with binary proximal outcomes · SiM · 2023-04-24 · 在第 17 页
- Allocation in platform trials to maintain comparability across time and eligibility · SiM · 2023-04-23 · 在第 17 页
- Design and analysis of factorial clinical trials: The impact of one treatment's effectiveness on the statistical power and required sample size of the other · SMMR · 2023-04-19 · 在第 18 页
- Biomarker‐based Bayesian randomized clinical trial design for identifying a target population · SiM · 2023-04-19 · 在第 18 页
- Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials · SiM · 2023-04-17 · 在第 18 页
- Models for cluster randomized designs using ranked set sampling · SiM · 2023-04-11 · 在第 18 页
- Simultaneous hypothesis testing for multiple competing risks in comparative clinical trials · SiM · 2023-04-10 · 在第 18 页
- Point estimation for adaptive trial designs II: Practical considerations and guidance · SiM · 2023-04-05 · 在第 19 页
- Estimating Optimal Individualized Treatment Rules with Multistate Processes · Biometrics · 2023-04-04 · 在第 19 页
- Online error rate control for platform trials · SiM · 2023-04-02 · 在第 20 页
- Promising zone two-stage design for a single-arm study with binary outcome · SMMR · 2023-03-30 · 在第 20 页
- A novel approach to assess dynamic treatment regimes embedded in a SMART with an ordinal outcome · SiM · 2023-03-30 · 在第 20 页
- Confidence intervals for discrete data in clinical research By VivekPradhan, Ashis K.Gangopadhyay, Sandeep M.Menon, CynthiaBasu, TathagataBanerjee, Chapman and Hall. 2021. pp. 226. $119.95. (hbk). ISBN: 978‐1138048980 · Biometrics · 2023-03-22 · 在第 21 页
- Scalable subsampling: computation, aggregation and inference · Biometrika · 2023-03-21 · 在第 21 页
- A Bayesian approach to study design and analysis with type I error rate control for response variables of mixed types · SiM · 2023-03-17 · 在第 21 页
- Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial · SMMR · 2023-03-15 · 在第 21 页
- Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effect · SMMR · 2023-03-15 · 在第 21 页
- Estimating the efficiency gain of covariate-adjusted analyses in future clinical trials using external data · JRSSB · 2023-03-14 · 在第 21 页
- Interim Monitoring of Sequential Multiple Assignment Randomized Trials Using Partial Information · Biometrics · 2023-03-10 · 在第 22 页
- Defining estimands in clinical trials: A unified procedure · SiM · 2023-03-08 · 在第 22 页
- Sample size calculation for randomized trials via inverse probability of response weighting when outcome data are missing at random · SiM · 2023-03-06 · 在第 22 页
- Covariate-Adjusted Response-Adaptive Designs Based on Semiparametric Approaches · Biometrics · 2023-03-04 · 在第 22 页
- Flexible template matching for observational study design · SiM · 2023-03-02 · 在第 22 页
- Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons · SiM · 2023-02-27 · 在第 23 页
- Group sequential multi‐arm multi‐stage trial design with treatment selection · SiM · 2023-02-20 · 在第 23 页
- Data-dependent early completion of dose-finding trials for drug-combination · SMMR · 2023-02-12 · 在第 24 页
- The Personalised Randomized Controlled Trial: Evaluation of a new trial design · SiM · 2023-02-02 · 在第 24 页
- Revisiting sample size planning for receiver operating characteristic studies: A confidence interval approach with precision and assurance · SMMR · 2023-02-01 · 在第 24 页
- Multistate models as a framework for estimand specification in clinical trials of complex processes · SiM · 2023-01-31 · 在第 24 页
- Two‐phase designs with current status data · SiM · 2023-01-23 · 在第 25 页
- Practical approaches to Bayesian sample size determination in non‐inferiority trials with binary outcomes · SiM · 2023-01-20 · 在第 25 页
- Unit information prior for incorporating real-world evidence into randomized controlled trials · SMMR · 2023-01-19 · 在第 25 页
- Minimum sample size for developing a multivariable prediction model using multinomial logistic regression · SMMR · 2023-01-19 · 在第 25 页
- Multiple assessments of non‐inferiority trials with ordinal endpoints · SiM · 2023-01-17 · 在第 25 页
- Bayesian Inference for a Principal Stratum Estimand on Recurrent Events Truncated by Death · Biometrics · 2023-01-17 · 在第 25 页
- Taking a chance: How likely am I to receive my preferred treatment in a clinical trial? · SMMR · 2023-01-10 · 在第 26 页
- Adjusting for Publication Bias in Meta-Analysis via Inverse Probability Weighting Using Clinical Trial Registries · Biometrics · 2023-01-05 · 在第 26 页
- A novel power prior approach for borrowing historical control data in clinical trials · SMMR · 2023-01-04 · 在第 26 页
- Bayesian Design of Multi-Regional Clinical Trials with Time-to-Event Endpoints · Biometrics · 2023-01-03 · 在第 27 页
- Bagging in overparameterized learning: Risk characterization and risk monotonization · JMLR · 2023 · 在第 37 页